|
LamisilDrug - Lamisil The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Terbinafine Hydrochloride
Strength -
EQ 250MG BASE
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
020539
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
May 10, 1996
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Lamisil
Lamisil 1% Gel; Topical
Lamisil 1% Cream; Topical Lamisil 1% Cream; Topical Lamisil 1% Solution; Topical Lamisil At 1% Solution; Topical Lamisil At 1% Spray; Topical Lamisil Eq 250mg Base Tablet; Oral Terazosin Hcl Eq 1mg Base Tablet; Oral Terazosin Hcl Eq 2mg Base Tablet; Oral Terazosin Hcl Eq 5mg Base Tablet; Oral NewDrugInformation |